HB282 Alabama 2015 Session

Updated Feb 24, 2026

Summary

Primary Sponsor: James E. Buskey
Democrat
Session: Regular Session 2015
Title: Sickle Cell Oversight and Regulatory Commission, authorized to make rules, Secs. 22-10B-2, 22-10B-3 am'd.
Summary: HB282 strengthens governance of Alabama's Sickle Cell Oversight and Regulatory Commission by adding an attendance-based removal rule and giving the commission authority to set rules for complaints and service delivery.
What This Bill Does
It would allow removing a commission member who fails to attend three consecutive properly noticed meetings. It would authorize the commission to promulgate rules for handling complaints about services and for managing statewide sickle cell programs, including guidelines to standardize service delivery. It would designate the commission as the state agency responsible for insuring the delivery of sickle cell services statewide and for establishing geographic service delivery boundaries, while requiring annual diversity reporting to the Legislature.

Who It Affects
Group 1: Commission members and their appointing authorities — they could be removed for missing three consecutive meetings.
Group 2: People with sickle cell disease and their families in Alabama — they could see more consistent, standardized delivery of services and a formal process to file and resolve complaints.

Key Provisions
Adds a provision allowing removal of a commission member after that member fails to attend three consecutive properly noticed meetings.
Authorizes the commission to promulgate rules for handling complaints about services and for managing statewide sickle cell programs, and to issue guidelines to create uniform service delivery.
Designates the commission as the state agency responsible for insuring the delivery of sickle cell services statewide and for establishing geographical service delivery boundaries.
Preserves a diverse commission composition and requires annual reporting to the Legislature on diversity and representation.

AI-generated summary using openai/gpt-5-nano on Feb 24, 2026. May contain errors — refer to the official bill text for accuracy.
Subjects: Sickle Cell Oversight and Regulatory Commission